City Sleep Lab LLC is categorized under Outpatient Drug Clinics in Renton, WA and active since 2009.
City Sleep Lab LLC was established in 2009, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Outpatient Drug Clinics business, which does work in the B2C market, and is classified as a Outpatient Drug Clinics, under code number 6219996 by the NAICS.
If you are seeking more information, feel free to contact Joel Durias, Owner at the company’s single location by writing to 95 South Tobin St # 205, Renton, Washington WA 98057 or by phoning (425) 738-0828. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | City Sleep Lab LLC |
| Contact Person: | Joel Durias, Owner |
| Address: | 95 South Tobin St # 205, Renton, Washington 98057 |
| Phone Number: | (425) 738-0828 |
| Website Address: | citysleeplab.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2009 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Outpatient Drug Clinics |
| SIC Code: | 8093 |
| NAICS Code: | 6219996 |
| Share This Business: |
City Sleep Lab LLC was started in 2009 to provide professional Outpatient Drug Clinics under the SIC code 8093 and NAICS code 6219996. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Joel Durias, Owner for inquiries that concern City Sleep Lab LLC by calling the company number (425) 738-0828, as your correspondence is most welcome. Additionally, the physical location of the single location of City Sleep Lab LLC can be found at the coordinates 47.48382,-122.21626 as well as the street address 95 South Tobin St # 205 in Renton, Washington 98057.
For its online presence, you may visit City Sleep Lab LLC’s website at citysleeplab.com and engage with its social media outlets through on Twitter and on Facebook.